Literature DB >> 2276827

Concentrations of sulbactam/ampicillin in serum and lung tissue.

U Frank1, E Schmidt-Eisenlohr, A Joos-Württemberger, J Hasse, F Daschner.   

Abstract

The penetration of sulbactam plus ampicillin into lung tissue was studied in 15 patients undergoing thoracic surgery for pneumonectomy after the administration of 1 g of sulbactam plus 2 g of ampicillin as a 15 min intravenous short infusion. Ampicillin serum concentrations declined from 40.8 mg/l at 1 h to 18.8 mg/l 2-4 h after administration. Concomitant serum concentrations of sulbactam were 25.5 mg/l and 11.8 mg/l, respectively. In lung tissue, peak ampicillin concentrations of 35.6 mg/kg were reached 1.5 h after administration declining slowly to 26.8 mg/kg after 2-4 h. The respective sulbactam concentrations were 8.6 and 5.5 mg/kg. In our study sufficient sulbactam and ampicillin levels active against important pathogenic organisms causing community- and hospital-acquired respiratory tract infections have been achieved in lung tissue, suggesting that the combination sulbactam/ampicillin is suited for the treatment of most community- and hospital-acquired respiratory tract infections as well as for chemoprophylaxis and treatment of postoperative lung infections after thoracic surgery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276827     DOI: 10.1007/bf01647016

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Stomaching: a new concept in bacteriological sample preparation.

Authors:  A N Sharpe; A K Jackson
Journal:  Appl Microbiol       Date:  1972-08

2.  Penetration of ampicillin and sulbactam in the lower airways during respiratory infections.

Authors:  Y J Valcke; M T Rosseel; R A Pauwels; M G Bogaert; M E Van der Straeten
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species.

Authors:  U Frank; F D Daschner
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 6.  High-pressure liquid chromatography for quantitation of antimicrobial agents.

Authors:  T T Yoshikawa; S K Maitra; M C Schotz; L B Guze
Journal:  Rev Infect Dis       Date:  1980 Mar-Apr

Review 7.  Pharmacokinetics of sulbactam/ampicillin in humans: a review.

Authors:  G Foulds
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

8.  Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.

Authors:  J A Retsema; A R English; A Girard; J E Lynch; M Anderson; L Brennan; C Cimochowski; J Faiella; W Norcia; P Sawyer
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

9.  Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.

Authors:  K E Aldridge; C V Sanders; R L Marier
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

10.  High-performance liquid chromatographic assay of sulbactam using pre-column reaction with 1,2,4-triazole.

Authors:  J Haginaka; J Wakai; H Yasuda; T Uno; T Nakagawa
Journal:  J Chromatogr       Date:  1985-05-31
  10 in total
  7 in total

1.  Penetration of ampicillin and sulbactam into human epididymis and testis.

Authors:  T Klotz; M Braun; A Wildfeuer; U Engelmann
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

2.  [Ampicillin and sulbactam concentrations in the irradiated mandible after oral squamous cell cancer].

Authors:  H Heibel; M Scheer; T Reuther; M Hahn; R Trittler; H Egle; K Kümmerer; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07

3.  Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors.

Authors:  H Carsenti-Etesse; J Durant; F De Salvador; M Bensoussan; F Bensoussan; C Pradier; E Bernard; V Mondain; A Thabaut; P Dellamonica
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

4.  Concentrations of ampicillin and sulbactam in serum and in various compartments of the respiratory tract of patients.

Authors:  A Wildfeuer; K H Rühle; P L Bölcskei; M Springsklee
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

5.  Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.

Authors:  J Majcher-Peszynska; M Loebermann; S Klammt; S Frimmel; R G Mundkowski; T Welte; E C Reisinger; B Drewelow
Journal:  Infection       Date:  2013-08-01       Impact factor: 3.553

6.  Spondylodiscitis after lumbar microdiscectomy: effectiveness of two protocols of intraoperative antibiotic prophylaxis in 1167 cases.

Authors:  Luciano Mastronardi; Franco Rychlicki; Carlo Tatta; Letterio Morabito; Umberto Agrillo; Alessandro Ducati
Journal:  Neurosurg Rev       Date:  2005-07-19       Impact factor: 3.042

7.  A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Pneumonia: An Interim Analysis.

Authors:  Chutchawan Ungthammakhun; Vasin Vasikasin; Dhitiwat Changpradub
Journal:  Antibiotics (Basel)       Date:  2022-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.